LI
CBPO

Leap Investments’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Leap Investments’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$245K Buy
+2,400
New +$257K 0.16% 250

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Leap Investments's CBPO Position: Q2 2020 in Review

Leap Investments opened a new position in China Biologic Products Holdings, Inc. (CBPO) in Q2 2020: 2,400 shares worth $245K. The stake represents 0.16% of the portfolio and ranks #250 among its holdings.

91 funds tracked by Wall St. Rank hold CBPO as of Q2 2020.

  • Leap Investments held 2,400 shares of China Biologic Products Holdings, Inc. worth $245K as of Q2 2020.
  • China Biologic Products Holdings, Inc. was a new Leap Investments position in Q2 2020.
  • China Biologic Products Holdings, Inc. made up 0.16% of Leap Investments's portfolio in Q2 2020, its #250 holding.
  • 91 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.